KlebPhaCol is a barrier-free open-source, expandable phage and strain collection available for your biological question of interest.
It consists of 53 Klebsiella spp. - targeting phages and 74 clinical strains of Klebsiella spp. along with their associated data (including sequences). Stocks are available for request. Learn more about the collection here.
You can also add your phages and strains to the collection, make your data immediately available, and get instant recognition via a DOI!
About the collection
Introducing KlebPhaCol: Advancing Phage Therapy
Request the collection here
If you use any information or data from this website, please remember to cite us.
Read the KlebPhaCol preprint, out now!
The
Collection
-
Phage Stocks
All 53 phages are available upon request, for research purposes.
26 Myophages - 23 Siphophages - 4 Podophages
-
Bacterial Strains
Most 74 clinical isolates of Klebsiella spp. used in this collection are available upon request, for research purposes.
40 ST types - 32 KL types - 10 O-antigen
-
Characterisation of Phages
Phages have been sequenced, annotated and taxonomically assigned.
-
Characterisation of Bacterial Strains
Prophage identification as well as virulence, stress, antimicrobial resistance and defense genes for all 74 clinical isolates.
-
Host Range
All 53 Klebsiella spp. infecting phages were tested against the 74 clinical isolates of Klebsiella spp.
-
Transmission Electron Microscopy
All phages have been imaged by TEM.
How can you contribute?
We need you.
KlebPhaCol is a community-based collaborative platform. This means that you can add your Klebsiella spp. phages and strains to the collection, make your data immediately available, and get instant recognition via a DOI!
Our mission at KlebPhaCol is to accelerate the progress of phage therapy (and beyond). Therefore, you can also request the collection for your research endeavors and share the data immediately (or later) on this platform to facilitate data centralisation.
TEM
Gallery
KlebPhaCol has been shipped to 21 labs around the world!
(last updated: October 2024)
The Team
Additional contributors
Matthew Wand, UK Health Security Agency (UKHSA)
Mark Sutton, UKHSA
Sophie Lawson, UKHSA
Pieter-Jan Haas, University Medical Centre Utrecht
Agnieszka Łątka, Ghent University
Ilaria De Angelis, Ghent University
Yves Briers, Ghent University
Yan-Jiun Lee, New England Biolabs (NEB)
Peter Weigele, NEB
Ana Rita Costa, Delft University of Technology
Stan J.J. Brouns, Delft University of Technology
Francis Drobniewski, Imperial College
Elizabeth Sheridan, University Hospitals Dorset NHS Foundation Trust
Kordo Saeed, University Hospital Southampton NHS Foundation Trust
This research was funded by